Daily Archives: 02/02/2011

Australia: Docetaxel case

[Bloomberg] The interlocutory petition for restraining generic launch of Docetaxel in Australia is denied by federal judge. Docetaxel product per se is protected by patent no AU591309 (expiry: Feb 06, 2011) and composition is protected by patent no AU666859 (expiry: July 2012). … Continue reading

Posted in Patent case | Tagged , , , | Leave a comment

Patent & CI News: 02/02/2011

1) Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX™ Investigational Therapy for Acute Migraine (Yahoo finance); LEVADEX™ contains a proprietary formulation of dihydroergotamine (DHE). 2) Judge granted motion filed by Medeva Pharma Suisse AG and Warner Chilcott in Asacol lawsuit and awarded roxane … Continue reading

Posted in Daily interesting IP news | Leave a comment